UNH

UnitedHealth Group Incorporated

Quarterly revenue, EPS, free cash flow, valuation, and Rule of 40 scores for UnitedHealth Group Incorporated.

R40: 12$251.75B

$277.26+6.67 (+2.46%)● Live

Current Narrative

UnitedHealth is seen as undervalued with turnaround materializing (12% revenue growth) despite major decline (-20%, worst day since April 2025, $65B market cap erased). Guidance shows improvement vs 2025 margins with floor at 17x forward earnings. Berkshire's cost basis at $313-315 makes current $280s an opportunity to "be greedy when others are fearful."

News

Latest Coverage

NewsFeb 15

UnitedHealth's First Revenue Decline in Decades. The $439B Guidance Problem.

UnitedHealth guided 2026 revenue to $439B — down from $448B in 2025. It's the company's first annual revenue decline in decades, and the stock is paying for it.

R40

NewsJan 30

UnitedHealth Strong Buy

Insiders cashing out 22.8M; technical $148.29, consensus $230.63.

@CapitalWisdomAI on X

NewsJan 29

UNH Decline Signals Unease

Rising costs or tighter margins in healthcare; drop suggests consumer demand worries.

@EquityInsightsElite on X

NewsJan 28

UnitedHealth Extends Decline

Down -20%, erasing $65B market cap—worst day since April 2025.

@KobeissiLetter on X

NewsJan 27

UnitedHealth Turnaround Materializing

12% revenue growth; guidance shows improvement vs 2025 margins—floor at 17x forward earnings.

@patientinvestor on X

NewsJan 22

UNHappy Ending: How Big Challenges Nuked My UnitedHealth Thesis

Thesis knocked out; lost 20% market cap post-earnings.

Seeking Alpha

See all news →

Rule of 402025 Q4

12.4

✗ Below 40

Revenue Growth YoY+12.3%

FCF Margin+0.1%

History

2024 R40 +13

2025 R40 +15

ANALYST RATINGS

Hold$313

UNH

Hold$333

Downgrade

2025-10-29

Buy$406

Initiated

2025-10-14

Underperform$198

Downgrade

2025-07-31

Outperform$325

Reiterated

2025-07-30

Neutral$312

Downgrade

2025-06-11

Company timeline

Earnings release dates

Quarter	End date	Publication date	Source
2025 Q4	2025-12-31	2026-01-27	Link
2025 Q3	2025-09-30	2025-10-28	Link
2025 Q2	2025-06-30	2025-07-29	Link
2025 Q1	2025-03-31	2025-04-17	Link
2024 Q4	2024-12-31	2025-01-16	Link
2024 Q3	2024-09-30	2024-10-15	Link
2024 Q2	2024-06-30	2024-07-16	Link
2024 Q1	2024-03-31	2024-04-16	Link
2023 Q4	2023-12-31	2024-01-12	Link
2023 Q3	2023-09-30	2023-10-13	Link
2023 Q2	2023-06-30	2023-07-14	Link
2023 Q1	2023-03-31	2023-04-14	Link
2022 Q4	2022-12-31	2023-01-13	Link
2022 Q3	2022-09-30	2022-10-14	Link
2022 Q2	2022-06-30	2022-07-15	Link
2022 Q1	2022-03-31	2022-04-14	Link
2021 Q4	2021-12-31	2022-01-19	Link
2021 Q3	2021-09-30	2021-10-14	Link
2021 Q2	2021-06-30	2021-07-15	Link
2021 Q1	2021-03-31	2021-04-15	Link
2020 Q4	2020-12-31	2021-01-20	Link
2020 Q3	2020-09-30	2020-10-14	Link
2020 Q2	2020-06-30	2020-07-15	Link
2020 Q1	2020-03-31	2020-04-15	Link

Background

Company History

ExchangeNYSE

IPO DateOct 17, 1984

Shares Outstanding908.00Mi

1974

Founding as CharterMed

Founded by Richard T. Burke as Charter Med Incorporated in Minnesota, initially processing claims for doctors at the Hennepin County Medical Society.

1977

Establishment as UnitedHealthCare

UnitedHealthcare Corporation founded to purchase Charter Med and create a network-based health plan for seniors.

1984

Public Trading

Became a publicly traded company.

1998

Rebranding to UnitedHealth Group

Changed name to UnitedHealth Group and reorganized as a holding company for subsidiaries including UnitedHealthcare, Ovations, Uniprise, and Ingenix.

2006

Leadership Change Due to Scandal

William W. McGuire stepped down as chairman over employee stock options scandal; replaced by Stephen Hemsley as CEO.

2011

Formation of Optum

Optum formed to provide data and analytics, pharmacy care services, population health, healthcare delivery, and operations.

2019

Major Acquisitions

Optum acquired DaVita Medical Group for $4.3 billion and Equian for $3.2 billion; acquired PatientsLikeMe patient community platform.

2022

Acquisition of Change Healthcare

Acquired Change Healthcare for $8 billion after antitrust challenges; completed by September.

2024

Ransomware Attack on Change Healthcare

Subsidiary hit by ransomware, causing disruptions; led to DOJ probes on antitrust and overcharging, with CEO Andrew Witty testifying.

Leadership

Key Players

Stephen J. Hemsley

Chairman & CEO

Appointed CEO in May 2025 after Andrew Witty stepped down; has served as board Chair since 2019 and previously as CEO from 2006-2017.

Wayne S. DeVeydt

CFO

Appointed CFO in September 2025; former Anthem CFO (2007-2016) and Surgery Partners CEO; most recently a managing director at Bain Capital.

Tim Noel

CEO, UnitedHealthcare

Leads the health insurance division; joined UnitedHealthcare in 2007; succeeded Brian Thompson as CEO in January 2025; previously led Medicare Advantage plans.

Dr. Patrick Conway, M.D.

CEO, Optum

Appointed Optum CEO in May 2025; previously CEO of Optum Rx; practicing pediatrician with extensive public and private health care leadership experience.

Heather Cianfrocco

EVP, Governance, Compliance & Information Security

Moved from Optum CEO role in May 2025; previously held senior leadership roles across UnitedHealthcare and Optum; former practicing lawyer.

John F. Rex

Strategic Advisor to CEO

Former CFO (2016-2025); transitioned to advisory role in September 2025; joined UnitedHealth Group in 2012 as Optum CFO.

Short Interest

Short interest data unavailable for UNH.